In this episode, hosts Drs. Jason Silverman and Temara Hajjat talk to Drs. Michael Narkewicz and Zachary Sellers about screening, evaluation and management of children with cystic fibrosis with hepatobiliary involvement and advanced CF liver disease. We review the new consensus recommendations paper published in the May issue of Hepatology (open access link below).
Dr. Narkewicz is a pediatric gastroenterologist and transplant hepatologist at Children’s Hospital Colorado and professor of pediatrics at the University of Colorado with a strong clinical and research interest in cystic fibrosis and in particular on liver disease in cystic fibrosis who has presented and published extensively in this area over his career.
Dr. Sellers is a pediatric gastroenterologist, Adjunct professor and physician-scientist at Stanford with clinical interests in the GI manifestations of cystic fibrosis and pancreatitis in children who has worked with the INSPPIRE consortium and has presented and published widely on CF and liver disease in CF.
Learning objectives:
Papers discussed in this episode (both are open access!:
This episode is eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!
As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.
Check out our merch website!
Follow us on Twitter, Facebook and Instagram for all the latest news and upcoming episodes.
Click here to support the show.